Targeted Delivery of β-Glucosidase-Loaded Magnetic Nanoparticles: Effect of External Magnetic Field Duration and Intensity

References

• Yamaizumi M , MekadaE, UchidaT, OkadaY. One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell15(1), 245–250 (1978).
   PubMed Web of Science ®Google Scholar
• Cui H , HanW, ZhangJ, ZhangZ, SuX. Advances in the regulatory effects of bioactive peptides on metabolic signaling pathways in tumor cells. J. Cancer10(11), 2425–2433 (2019).
   PubMed Web of Science ®Google Scholar
• Mazor R , KingEM, PastanI. Strategies to reduce the immunogenicity of recombinant immunotoxins. Am. J. Pathol.188(8), 1736–1743 (2018).
   PubMed Web of Science ®Google Scholar
• Lambert JM , MorrisCQ. Antibody-drug conjugates (ADCs) for personalized treatment of solid tumors: a review. Adv. Ther.34(5), 1015–1035 (2017).
   PubMed Web of Science ®Google Scholar
• Govindan SV , SharkeyRM, GoldenbergDM. Prospects and progress of antibody–drug conjugates in solid tumor therapies. Expert. Opin. Biol. Ther.16(7), 883–893 (2016).
   PubMed Web of Science ®Google Scholar
• Wong J , ProutJ, SeifalianA. Magnetic nanoparticles: new perspectives in drug delivery. Curr. Pharm. Des.23(20), 2908–2917 (2017).
   PubMedGoogle Scholar
• Khramtsov P , KropanevaM, ByzovIet al. Conjugation of carbon coated-iron nanoparticles with biomolecules for NMR-based assay. Colloids Surf. B176, 256–264 (2019).
   PubMedGoogle Scholar
• Albinali KE , ZaghoMM, DengY, ElzatahryAA. A perspective on magnetic core-shell carriers for responsive and targeted drug delivery systems. Int. J. Nanomedicine14, 1707–1723 (2019).
   PubMed Web of Science ®Google Scholar
• Grifantini R , TarantaM, GherardiniLet al. Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer. J. Control Release280, 76–86 (2018).
   PubMed Web of Science ®Google Scholar
• Schleich N , PoC, JacobsDet al. Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy. J. Control Rel.194, 82–91 (2014).
   PubMed Web of Science ®Google Scholar
• Lungu II , RădulescuM, MogoşanuGD, GrumezescuAM. pH sensitive core-shell magnetic nanoparticles for targeted drug delivery in cancer therapy. Rom. J. Morphol. Embryol.57(1), 23–32 (2016).
   PubMed Web of Science ®Google Scholar
• Liu E , ZhangM, CuiHet al. Tat-functionalized Ag-Fe3O4 nano-composites as tissue-penetrating vehicles for tumor magnetictargeting and drug delivery. Acta Pharm. Sin. B8(6), 956–968 (2018).
   PubMedGoogle Scholar
• Bae YH , ParkK. Targeted drug delivery to tumors: myths, reality and possibility. J. Control Rel.153(3), 198–205 (2011).
   PubMed Web of Science ®Google Scholar
• Arami H , KhandharA, LiggittD, KrishnanKM. In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem. Soc. Rev.44(23), 8576–8607 (2015).
   PubMed Web of Science ®Google Scholar
• Baronzio G , ParmarG, BaronzioM. Overview of methods for overcoming hindrance to drug delivery to tumors, with special attention to tumor interstitial fluid. Front. Oncol.5, 165 (2015).
   PubMedGoogle Scholar
• Janikowska A , MatuszakJ, LyerSet al. A novel human artery model to assess the magnetic accumulation of SPIONs under flow conditions. Sci. Rep.7, 42314 (2017).
   PubMedGoogle Scholar
• Zhang S , WuL, CaoJet al. Effect of magnetic nanoparticles size on rheumatoid arthritis targeting and photothermal therapy. Colloids Surf. B170, 224–232 (2018).
   PubMed Web of Science ®Google Scholar
• Zhou J , ZhangJ, GaoW. Enhanced and selective delivery of enzyme therapy to 9L-glioma tumor via magnetic targeting of PEG-modified, β-glucosidase-conjugated iron oxide nanoparticles. Int. J. Nanomedicine9, 2905–2917 (2014).
   PubMed Web of Science ®Google Scholar
• Chertok B , DavidAE, YangVC. Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography. J. Control Rel.155(3), 393–399 (2011).
   PubMed Web of Science ®Google Scholar
• Liu JF , JangB, IssadoreD, TsourkasA. Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.11(6), e1571 (2019).
   PubMedGoogle Scholar
• Moros M , Idiago-LópezJ, AsínLet al. Triggering antitumoural drug release and gene expression by magnetic hyperthermia. Adv. Drug Deliv. Rev.138, 326–343 (2019).
   PubMed Web of Science ®Google Scholar
• Rühle B , DatzS, ArgyoC, BeinT, ZinkJI. A molecular nanocap activated by superparamagnetic heating for externally stimulated cargorelease. Chem. Commun. (Camb.)52(9), 1843–1846 (2016).
   PubMedGoogle Scholar
• Park J , KadasalaNR, AbouelmagdSAet al. Polymer-iron oxide composite nanoparticles for EPR-independent drug delivery. Biomaterials101, 285–295 (2016).
   PubMed Web of Science ®Google Scholar
• Liu YL , ChenD, ShangP, YinDC. A review of magnet systems for targeted drug delivery. J. Control Rel.302, 90–104 (2019).
   PubMed Web of Science ®Google Scholar
• Liu JF , LanZ, FerrariCet al. Use of oppositely polarized external magnets to improve the accumulation and penetration of magnetic nanocarriers into solid tumors. ACS Nano14(1), 142–152 (2020).
   PubMedGoogle Scholar
• Xu Q , HouJ, RaoJ, LiGH, LiuYL, ZhouJ. PEG modification enhances the in vivo stability of bioactive proteins immobilized on magnetic nanoparticles. Biotechnol. Lett. doi: 10.1007/s10529-020-02867-4 (2020) ( Epub ahead of print).
   Google Scholar
• Tseng SH , ChouMY, ChuIM. Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy. Int. J. Nanomedicine10, 3663–3685 (2015).
   PubMed Web of Science ®Google Scholar
• Yu F , ZhangL, HuangY, SunK, DavidAE, YangVC. The magnetophoretic mobility and superparamagnetism of core-shell iron oxide nanoparticles with dual targeting and imaging functionality. Biomaterials31(22), 5842–5848 (2010).
   PubMedGoogle Scholar
• Zhou J , ZhangJ, DavidAE, YangVC. Magnetic tumor targeting of β- glucosidase immobilized iron oxide nanoparticles. Nanotechnology24(37), 375102 (2013).
   PubMedGoogle Scholar
• Chertok B , ColeAJ, DavidAE, YangVC. Comparison of electron spin resonance spectroscopy and inductively-coupled plasma optical emission spectroscopy for biodistribution analysis of iron-oxide nanoparticles. Mol. Pharm.7(2), 375–385 (2010).
   PubMed Web of Science ®Google Scholar
• Chertok B , DavidAE, YangVC. Magnetically-enabled and MR-monitored selective brain tumor protein delivery in rats via magnetic nanocarriers. Biomaterials32(26), 6245–6253 (2011).
   PubMed Web of Science ®Google Scholar
• Mousavikhamene Z , AbdekhodaieMJ, AhmadiehH. Facilitation of transscleral drug delivery by drug loaded magnetic polymeric particles. Mater. Sci. Eng. C Mater. Biol. Appl.79, 812–820 (2017).
   PubMedGoogle Scholar
• Al-Jamal KT , BaiJ, WangJTet al. Magnetic drug targeting: preclinical in vivo studies, mathematical modeling and extrapolation to humans. Nano Lett.16(9), 5652–5660 (2016).
   PubMed Web of Science ®Google Scholar
• Shaw S , MurthyPV, SibandaP. Magnetic drug targeting in a permeable microvessel. Microvasc. Res.85, 77–85 (2013).
   PubMed Web of Science ®Google Scholar
• Hennig TL , UnterwegerH, LyerS, AlexiouC, CichaI. Magnetic accumulation of SPIONs under arterial flow conditions: effect of serum and red blood cells. Molecules24(14), 2588 (2019).
   PubMedGoogle Scholar
• Gomez-Garcia MJ , DoironAL, SteeleRRMet al. Nanoparticle localization in blood vessels: dependence on fluid shear stress, flow disturbances and flow-induced changes in endothelial physiology. Nanoscale10(32), 15249–15261 (2018).
   PubMedGoogle Scholar
• Carenza E , JordanO, Martínez-SanSegundo Pet al. Encapsulation of VEGF165 into magnetic PLGA nanocapsules for potential local delivery and bioactivity in human brain endothelial cells. J. Mater. Chem. B3(12), 2538–2544 (2015).
   PubMed Web of Science ®Google Scholar
• Rasaneh S , DadrasMR. The possibility of using magnetic nanoparticles to increase the therapeutic efficiency of herceptin antibody. Biomed. Tech. (Berl.)60(5), 485–490 (2015).
   PubMedGoogle Scholar
• Mei KC , BaiJ, LorrioS, WangJT, Al-JamalKT. Investigating the effect of tumor vascularization on magnetic targeting in vivo using retrospective design of experiment. Biomaterials106, 276–285 (2016).
   PubMed Web of Science ®Google Scholar
• Guo X , LiW, LuoLet al. External magnetic field-enhanced chemo-photothermal combination tumor therapy via iron oxide nanoparticles. ACS Appl. Mater. Interfaces9(19), 16581–16593 (2017).
   PubMedGoogle Scholar
• Watanabe A , TanakaH, SakuraiYet al. Effect of particle size on their accumulation in an inflammatory lesion in a dextran sulfate sodium (DSS)-induced colitis model. Int. J. Pharm.509(1–2), 118–122 (2016).
   PubMedGoogle Scholar
• Danhier F , DanhierP, DeSaedeleer CJet al. Paclitaxel-loaded micelles enhance transvascular permeability and retention of nanomedicines in tumors. Int. J. Pharm.479(2), 399–407 (2015).
   PubMedGoogle Scholar
• McMasters J , PohS, LinJB, PanitchA. Delivery of anti-inflammatory peptides from hollow PEGylated poly(NIPAM) nanoparticles reduces inflammation in an ex vivo osteoarthritis model. J. Control Rel.258, 161–170 (2017).
   PubMed Web of Science ®Google Scholar
• Kim W , HallerC, DaiEet al. Targeted antithrombotic protein micelles. Angew. Chem. Int. Ed. Engl.54(5), 1461–1465 (2015).
   PubMed Web of Science ®Google Scholar